Clive Carter

Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency

Hassan Abolhassani, Yasser M. El‐Sherbiny, Gururaj Arumugakani et al. · Journal of Clinical Immunology · 2019 · 34 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy

Gina B. Scott, Clive Carter, Christopher Parrish et al. · Cellular Immunology · 2015 · 25 citations

Life Sciences, Immunology, Oncology +16

Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses

Benazir Saleem, Rebecca L. Ross, Lesley-Anne Bissell et al. · RMD Open · 2022 · 24 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder

Beibei Wu, Laura Rice, Jennifer Shrimpton et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · 2021 · 20 citations

Life Sciences, Genetics, Molecular Genetics +17

A novel RAG1 mutation reveals a critical in vivo role for HMGB1/2 during V(D)J recombination

Daniel Thwaites, Clive Carter, Dylan Lawless et al. · Blood · 2018 · 19 citations · Full text

Medicine, Genetics, Molecular Genetics +15